|
| [February 26, 2013] |
 |
Biomet to Present at 2013 Goldman Sachs Healthcare Leveraged Finance Conference
WARSAW, Ind. --(Business Wire)--
Biomet, Inc. announced today that it will be participating in the 2013
Goldman Sachs Healthcare & Leveraged Finance Conference in New York, New
York, on March 6, 2013 at 8:40 a.m. local time.
A link to the presentation will be available on Biomet's website at www.biomet.com
in the Investor Section.
About Biomet
Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. Biomet's product portfolio
encompasses large joint reconstructive products, including orthopedic
joint replacement devices, and bone cements and accessories; sports
medicine, extremities and trauma products, including internal and
external orthopedic fixation devices; spine and bone healing products,
including spine hardware, spinal stimulation devices, and
orthobiologics, as well as electrical bone growth stimulators and
softgoods and bracing; dental reconstructive products; and other
products, including microfixation products and autologous therapies.
Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently
distribute products in approximately 90 countries
[ Sports Techy's Homepage ]
|
